A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C.
Escalante CP, et al. Among authors: wang x, wang xs.
Cancer J. 2014 Jan-Feb;20(1):8-14. doi: 10.1097/PPO.0000000000000018.
Cancer J. 2014.
PMID: 24445757
Free PMC article.
Clinical Trial.